Pichette et al. (45) included multiple biomarkers such as BNP in the preoperative evaluation of patients with heart failure or at risk of heart failure but also suggested that goals should be individualized, with an individualized target threshold and consideration of delayed surgery in patients with rapidly rising BNP levels. This evidence concerns the gene NPPB and heart failure.